Navigation Links
For Drug Company Whistleblowers, Hardship Often Follows
Date:5/12/2010

More equitable rewards, stronger anti-retaliation provisions needed, study authors say

WEDNESDAY, May 12 (HealthDay News) -- Ordinary citizens who "blow the whistle" on drug companies for ripping off Medicare and Medicaid are motivated by ethics more so than the financial rewards they reap, yet the personal toll they endure can be substantial and long-lasting, a new study finds.

For 82 percent of these "insiders" -- pharmaceutical manufacturer employees who become whistleblowers -- filing a health fraud complaint led to unwanted pressures from their employer, including being fired, intimidated or blackballed.

"A lot of them express a very strong ethical compass that they think guides them but, boy, they really do suffer a lot for the public good that they perform," said lead author Dr. Aaron S. Kesselheim, an instructor in medicine at Harvard Medical School and an associate physician in the division of pharmacoepidemiology and pharmacoeconomics at Brigham and Women's Hospital in Boston.

The study, described in a special report published in the May 13 issue of the New England Journal of Medicine, provides what may be the first solid data on the experiences of those who participate in litigation under the federal False Claims Act.

"This has been described by anecdote, but I have not seen it quantified in this way before," said Marcia Boumil, associate professor of public health and community medicine at Tufts University School of Medicine in Boston, whose recent paper in the Journal of Public Health Policy examined whistleblowing in the United States, England, Canada and Australia.

The study also has important implications for the anti-fraud efforts of the U.S. Justice Department, which currently has a backlog of more than 1,000 "qui tam" (whistleblower) cases, according to the report.

In addition to providing sufficient financial incentives to encourage whistleblowers,
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign
2. The Advisory Board Company Reports Results For Quarter Ended 12/31/09
3. Steritech Retains Leavitt Partners to Advise the Company on Emerging Food Safety Concerns and Regulation
4. Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company
5. Company Dedicated to Protecting American Homes Reaches Out To Haitians Who Have Lost Theirs
6. IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2010 Small and Mid Cap Conference
7. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
8. G Marks the Spot: Good Vibrations Proclaims February as National G-Spot Month -- Sex Toy Company Says "It Most Certainly Does Exist!"
9. Head Lice Company With a Social Conscience Defies the Recession
10. Open Source Company Kitware Announces New Availability to its MIDAS Server to Further Research Collaboration and Open Science
11. Staffing Company Sends Anesthesiologists to Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... New York (PRWEB) , ... June 29, 2015 ... ... lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against C.R. Bard, Inc. and Ethicon, Inc. ... court documents, the proceedings’ next Case Management Conference is to be convened on ...
(Date:6/29/2015)... Valley, CA (PRWEB) , ... June 29, 2015 , ... ... treatments designed to lift and tighten sagging skin. Ulthera is a special treatment that ... Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is highly targeted ...
(Date:6/29/2015)... ... June 29, 2015 , ... Bionops Laboratories has released the ... French consumers. , The specialized eye health formulation contains a variety of ingredients ... In addition to Citicoline (Cognizin®), Biomacula provides necessary doses of Vitamin E, Glutathione, ...
(Date:6/29/2015)... ... June 29, 2015 , ... Blue Cross ... leaders with the Commercial Markets division, which includes the company’s commercial health plan ... companies with regional, national and international reach. Mary Ellen Anderson now holds the ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... informed, responsible and legal access to Health Canada's medical cannabis program, today officially ... education on how Health Canada's medical marijuana system works. Members are connected with ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 3
... Macpherson, the Australian model says that she had a lot of ... appreciate her "amazing body" //. ,Macpherson hated her tall figure ... says, "I have to say I had an amazing body and ... I felt so Amazonian and it wasn't really fashionable at the ...
... that patients on medications for blood pressure and cholesterol ... can now safely consume grapefruit juice- which has lot ... juice for some was due to some studies that ... dangerous side effects. ,The answer has been found by ...
... Day, India’s premier retail chain of coffee cafes, on opening its ... to reach the target of 500 by the year 2007. // ... are very happy to have played a large role in firmly ... director of the Amalgamated Bean Coffee Trading Company Ltd., the parent ...
... has been documented in Acute Coronary Syndrome patients, instituted ... the Society for Cardiovascular Angiography and Interventions (SCAI) // ... ,By combining data from nine randomized clinical trials ... the analysis was able to put a sharper focus ...
... belief that adolescent boys tend to take romance for a ... to heart matters, they might not be so fleeting after ... outside, an adolescent boy fails to communicate his emotions, leading ... ,Boys are more vulnerable and emotionally engaged in romantic ...
... journal Carcinogenesis show that exercise can offer protection against cancer. ... round the clock access to wheels took longer to develop ... a restricted diet had a healthy effect on mice by ... first study exposed mice to ultraviolet B rays of the ...
Cached Medicine News:Health News:Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival 2Health News:Teenage Boys More Vulnerable And Emotionally Engaged In Romantic Relationships 2Health News:Teenage Boys More Vulnerable And Emotionally Engaged In Romantic Relationships 3
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: